Skip to content

The 12th Annual Pharmaceutical Compliance Congress

Loeb & Loeb LLP is proud to sponsor The 12th Annual Pharmaceutical Compliance Congress where partner Scott Liebman will be presenting on "Impact of New Guidance — Monitor and Manage Product and Brand Information via Digital Media" as well as a speaking on a panel titled "A View from the Outside —Mitigate Risk and Prepare for the Future."

From the conference website:
Widely recognized as the most comprehensive, senior-level compliance meeting, CBI's esteemed Pharmaceutical Compliance Congress (PCC) attracts more than 400 industry leaders, including dozens of CCOs and their legal, compliance and regulatory teams. With unmatched, an expert speaking faculty and the who’s who in compliance in attendance, PCC is the must-attend event for your organization in 2015!

Delivering the most robust agenda in the industry, in 2014 PCC featured insights from 125 industry experts, more than two dozen CCOs and first-hand feedback from government agencies, including DOJ, FDA and U.S. Attorneys.

Program Highlights:

  • The in-depth agenda was built with specific functional responsibilities in mind — monitoring, training, investigations, R&D compliance and so much more!
  • Dedicated, high-level content for senior-level professionals, as well as fundamental sessions tailored to those new to the compliance space
  • Pertinent, pressing issues facing compliance professionals, such as FCPA, considerations for BRIC nations, compliance for specialty products, third-party investigations and more!
  • The ever-popular Enforcement Panel
  • The industry’s only CCO Summit